Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Biggest Surprises of 2006

Feb 01 2007

• By Kate Rawson

Related Content

Omnitrope Clears FDA: Is the Next Hurdle Congress?

Jun 01 2006

Plan B Approval Is Good News for OTC Switch of Xenical

Sep 01 2006

New Years' Resolutions

Feb 01 2006

The Acomplia Paradox: Primary Care Drug, Targeted Population

Dec 01 2006

The Approval Drought Continues

Feb 01 2007

Related Companies

Novartis AG

Sanofi

Barr Pharmaceuticals

Pfizer Inc.

Merck & Co., Inc.

Additional Topics

Business Strategies Regulation

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window